Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial.

Wärnberg, Fredrik ; Garmo, Hans ; Emdin, Stefan ; Hedberg, Veronica ; Adwall, Linda ; Sandelin, Kerstin ; Ringberg, Anita LU ; Karlsson, Per ; Arnesson, Lars-Gunnar and Anderson, Harald LU , et al. (2014) In Journal of Clinical Oncology 32(32). p.3613-3613
Abstract
Four randomized studies show that adjuvant radiotherapy (RT) lowers the risk of subsequent ipsilateral breast events (IBEs) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) by approximately 50% after 10 to 15 years. We present 20 years of follow-up data for the SweDCIS trial.
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Clinical Oncology
volume
32
issue
32
pages
3613 - 3613
publisher
American Society of Clinical Oncology
external identifiers
  • pmid:25311220
  • wos:000344860000010
  • scopus:84911485938
  • pmid:25311220
ISSN
1527-7755
DOI
10.1200/JCO.2014.56.2595
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Surgery Research Unit (013242220), Paediatrics (Lund) (013002000), Pathology, (Lund) (013030000), Cancer Epidemiology (013007100)
id
d03549c4-8290-49f8-a494-3b90f1821bf4 (old id 4736994)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25311220?dopt=Abstract
date added to LUP
2016-04-01 10:23:31
date last changed
2024-01-21 12:57:59
@article{d03549c4-8290-49f8-a494-3b90f1821bf4,
  abstract     = {{Four randomized studies show that adjuvant radiotherapy (RT) lowers the risk of subsequent ipsilateral breast events (IBEs) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) by approximately 50% after 10 to 15 years. We present 20 years of follow-up data for the SweDCIS trial.}},
  author       = {{Wärnberg, Fredrik and Garmo, Hans and Emdin, Stefan and Hedberg, Veronica and Adwall, Linda and Sandelin, Kerstin and Ringberg, Anita and Karlsson, Per and Arnesson, Lars-Gunnar and Anderson, Harald and Jirström, Karin and Holmberg, Lars}},
  issn         = {{1527-7755}},
  language     = {{eng}},
  number       = {{32}},
  pages        = {{3613--3613}},
  publisher    = {{American Society of Clinical Oncology}},
  series       = {{Journal of Clinical Oncology}},
  title        = {{Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial.}},
  url          = {{http://dx.doi.org/10.1200/JCO.2014.56.2595}},
  doi          = {{10.1200/JCO.2014.56.2595}},
  volume       = {{32}},
  year         = {{2014}},
}